Flight Centre Travel Group Limited (ASX:FLT) Releases Half-Year Results
Flight Centre Travel Group (ASX:FLT) reports a 7% increase in underlying PBT and a 10% rise in interim dividend for H1 FY25.
Tag: Investor Relations
PointsBet Holdings Limited (ASX:PBH) Announces H1 FY25 Results
PointsBet Holdings Limited (ASX:PBH) reports a 6% revenue increase in H1 FY25 and announces its acquisition by MIXI.
Euroz Hartleys Group Limited (ASX:EZL) Reports Half-Year Financial Results
Euroz Hartleys Group Limited (ASX:EZL) reports a 501% rise in net profit and declares a 2-cent interim dividend.
Acrux (ASX:ACR) Reports A$20M Revenue and Announces US Product Launches
Acrux (ASX:ACR) reports A$20 million revenue for FY23-FY24 and announces new US product launches, bolstering its presence in the pharmaceutical market.
Archer Materials Limited (ASX:AXE) Enhances Biochip Feasibility and Advances Development Roadmap
Archer Materials Limited (ASX:AXE) improves Biochip’s potassium detection accuracy, advances to human blood testing, and plans regulatory engagements.
Dimerix Limited (ASX:DXB) Reports Half-Year Financial Results
Dimerix Limited (ASX:DXB) reports a 113% revenue increase in the half-year ended December 2024, alongside a 93% rise in losses.
Titomic Limited (ASX:TTT) Expands US Operations with Huntsville Acquisition
Titomic Limited (ASX:TTT) expands US operations by acquiring a Huntsville facility, securing financing, and enhancing manufacturing capabilities.
Great Boulder Resources (ASX:GBR) Unveils New Shallow Gold Zones at Side Well South
Great Boulder Resources (ASX:GBR) unveils new shallow gold zones at Side Well South with significant drilling results, enhancing its exploration portfolio.
Reach Resources Limited (ASX:RR1) Confirms Initial Assay Results Impact Securities
Reach Resources Limited (ASX:RR1) confirms initial assay results from Murchison South have a material impact on its securities, ensuring ASX listing compliance.
4DMedical Limited (ASX:4DX) Launches Share Purchase Plan
4DMedical Limited (ASX:4DX) launches a Share Purchase Plan, enabling shareholders to buy up to $30,000 in new shares without fees.